PharmChem (PharmChem) ROCE % : 47.18% (As of Sep. 2023)

View and export this data going back to 2003. Start your Free Trial

What is PharmChem ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PharmChem's annualized ROCE % for the quarter that ended in Sep. 2023 was 47.18%.

PharmChem ROCE % Historical Data

The historical data trend for PharmChem's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmChem ROCE % Chart

PharmChem Annual Data

Trend

Dec93

Dec94

Dec95

Dec96

Dec97

Dec98

Dec99

Dec00

Dec01

Dec02

ROCE %

Get a 7-Day Free Trial

10.30

19.20

3.64

-42.14

-7.01

PharmChem Quarterly Data
	Jun99	Sep99	Dec99	Mar00	Jun00	Sep00	Dec00	Mar01	Jun01	Sep01	Dec01	Mar02	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Sep22	Sep23
ROCE %	Get a 7-Day Free Trial															-21.98	-14.48	-9.99	9.06	47.18

PharmChem ROCE % Calculation

PharmChem's annualized ROCE % for the fiscal year that ended in Dec. 2002 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2002 )		(A: Dec. 2001 )		(A: Dec. 2002 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2002 )		(A: Dec. 2001 )		(A: Dec. 2002 )
	=	-0.783	/	( ( (28.497 - 17.325)	+	(22.667 - 11.494) )	/ 2 )
	=	-0.783	/	( (11.172	+	11.173)	/ 2 )
	=	-0.783	/	11.1725
	=	-7.01 %

PharmChem's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Sep. 2022 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Sep. 2022 )		(Q: Sep. 2023 )
	=	1.212	/	( ( (0 - 0)	+	(3.252 - 0.683) )	/ 1 )
	=	1.212	/	( ( 0	+	2.569 )	/ 1 )
	=	1.212	/	2.569
	=	47.18 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

PharmChem (OTCPK:PCHM) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

PharmChem ROCE % Related Terms

Thank you for viewing the detailed overview of PharmChem's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmChem (PharmChem) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PharmChem Inc (OTCPK:PCHM) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2411 E. Loop 820 N, Fort Worth, TX, USA, 76118

Website

https://www.pharmchek.com

PharmChem Inc is engaged in selling and distributing of the PharmChek Sweat Patch Device. PharmChek is a system that uses sweat to detect the presence of illegal drugs. It consists of a transparent polyurethane outer covering, a small absorbent pad, and a release liner. Geographically the activities are carried out throughout the United States.

Executives

Alto Investors Palo	10 percent owner	470 UNIVERSITY AVENUE, PALO ALTO CA 94301
Micro Cap Partners Lp	10 percent owner

PharmChem (PharmChem) Headlines

From GuruFocus

PharmChem (PCHM) Announces Response To Opposition

By PRNewswire PRNewswire • 08-11-2021